Clinical Trials Logo

Postmenopausal Women clinical trials

View clinical trials related to Postmenopausal Women.

Filter by:

NCT ID: NCT03708354 Withdrawn - Clinical trials for Postmenopausal Women

Tocotrienols for Skeletal Muscle Health

VitE-muscle
Start date: April 15, 2019
Phase: Phase 1/Phase 2
Study type: Interventional

Sarcopenia, defined as a reduction in muscle mass and strength, is a major health concern for postmenopausal women. Evidence suggests that lowering inflammation levels is an important strategy to help mitigate age-related muscle dysfunction and loss. In this pilot study, the investigators will study a tocotrienol (vitamin-E isomer) intervention for feasibility and quantify its effects on postmenopausal women with low muscle strength. A double blind, placebo controlled trial will be conducted on fifty-two qualified subjects. The participants will be assigned to placebo or tocotrienols for 24 weeks. All participants will receive an Omron Alvita Optimized Pedometer. The investigators will measure muscular endurance, strength, and size and gut microbiome profiles at 0, 12, and 24 weeks. In addition, the investigators will measure serum and muscle inflammatory levels at 0 and 24 weeks. All data will be analyzed statistically at p<0.05.

NCT ID: NCT03705845 Recruiting - Obesity Clinical Trials

Tocotrienols for Obesity of Postmenopausal Women

VitE-obesity
Start date: March 15, 2019
Phase: Phase 1/Phase 2
Study type: Interventional

Postmenopausal women are at a risk of excessive weight gain, bone loss, hypertension, and metabolic syndrome. Obesity-induced chronic low-grade inflammation is initiated by excess nutrients in metabolic cells. Recent studies have indicated tocotrienols (one kind of vitamin E, a potent antioxidant) supplement may be good for mitigating negative impacts of obesity in postmenopausal women. The purpose of the study is to examine the effect of 24-week tocotrienols on obesity-associated outcome measurements in postmenopausal women. The investigators will enroll 60 qualified women at the start of the study and randomly assigned to no tocotrienols (placebo) or tocotrienols group for 24 weeks. Obesity-associated measurements will be recorded using blood, urine, adipose tissue, and fecal samples. All data will be analyzed statistically.

NCT ID: NCT03644472 Completed - Clinical trials for Postmenopausal Women

Postmenopausal Women and Their Endothelium

Start date: November 7, 2018
Phase: Phase 2
Study type: Interventional

The purpose of this study is to test the effects of a one time dose and 7-days of inorganic nitrate (supplied in the form of beetroot juice) on blood vessel function and resting blood pressure in healthy, postmenopausal women. Participants will drink beetroot juice and a placebo juice on separate visits where blood pressure and blood vessel function will be measured.

NCT ID: NCT03492983 Completed - Clinical trials for Postmenopausal Women

Effect of High Cocoa Content Chocolate on Health in Postmenopausal Women.

Start date: June 1, 2018
Phase: N/A
Study type: Interventional

This is a randomized clinical trial aimed at postmenopausal women aged 50 to 64 years old selected in urban primary care centers of two centers (Spain). Its objective is to evaluate the effects of the additional intake of high cocoa content chocolate on blood pressure, vascular function, body composition, quality of life and cognitive performance.

NCT ID: NCT03380000 Completed - Clinical trials for Postmenopausal Women

Effect of Beetroot Juice on Blood Pressure Regulation in Post Menopausal Women

Start date: September 12, 2014
Phase: Phase 2
Study type: Interventional

In this study the investigators will test the hypothesis that acute consumption of inorganic nitrate (supplied in concentrated beetroot juice) reduces artery stiffness and resting blood pressure, and lessens the rise in blood pressure during handgrip exercise in postmenopausal women. Understanding and improving artery function and blood pressure regulation in women is important because they undergo accelerated arterial stiffening after menopause and have much larger increases in blood pressure when they exercise compared with either premenopausal women or men of similar age.

NCT ID: NCT03191513 Completed - Healthy Adults Clinical Trials

The Acute Effects of Interesterification of Commercially Used Fats on Postprandial Fat Metabolism

INTERMET
Start date: June 12, 2017
Phase: N/A
Study type: Interventional

The purpose of this study is to investigate whether there are differences in postprandial metabolic indices following interesterified fats used commercially versus the corresponding un-interesterified blend.

NCT ID: NCT02352246 Not yet recruiting - Type 2 Diabetes Clinical Trials

HIIE and Abdominal Fat Mass in DT2 Postmenopausal Women

Start date: February 2015
Phase: N/A
Study type: Interventional

Postmenopausal women, as men, are more prone to central or android obesity. Abdominal fat mass is associated with an increase of cardiovascular diseases (CVD). In type 2 diabetic (T2D) patients, the risk of CVD mortality is more than double compared with that in age-matched subjects. Most exercise programs designed for weight loss have focused on steady-state exercise (SEE) of around 30 min at a moderate intensity several times a week. Disappointingly, these kinds of exercise programs have led to little or no fat loss (Shaw et al. 2006). Accumulating evidence suggests that high intensity intermittent exercise (HIIE) has the potential to be an effective exercise protocol for reducing fat of overweight individuals, especially at the abdominal level (Boutcher 2011, Kessler 2012). Despite these results, HIIE program has never been used in TD2 postmenopausal women to favor a specific decrease of abdominal fat mass. The aim of our study was to compare the effects of 16-week steady-state exercise (SSE) program with high intensity intermittent exercise (HIIE) program on total abdominal and visceral fat mass in T2D postmenopausal women. It is hypothesized that HIIE compared to SSE program would result in significantly greater reductions in total abdominal and visceral fat mass.

NCT ID: NCT02094144 Completed - Sedentary Lifestyle Clinical Trials

Health Benefits of a 6-month Brisk Walking Program in Sedentary Postmenopausal Women

ACTIMARCH
Start date: January 2008
Phase: N/A
Study type: Interventional

Community-dwelling women aged 55 or over are recruited at public meetings aimed at promoting physical activity in postmenopausal women. Women are eligible and enrolled in the study if they have no significant disease affecting lower limb function and if they have a sedentary lifestyle. All study participants provide written informed consent to participate to the study. Women are then randomized either to the control group (women have to maintain their lifestyle) or to the exercise group : 40 minutes of brisk walking 3d/wk for 6 months (two supervised sessions and one session performed one their own per week with a detailed program). The intensity of the program is adapted to the heart rate work and gradually increases over the 6-month program. The objective of the study is to determine the health benefits of brisk on walking ability, diet, muscle strength, balance, blood pressure, bone density, body weight, lean and fat mass, depression symptoms, behavioral, emotional responses, sleep quality, and biological indicators of health.

NCT ID: NCT01740076 Completed - Clinical trials for Postmenopausal Women

Soy Nuts and Cardiovascular Risk in Postmenopausal Women

Start date: September 2001
Phase: N/A
Study type: Interventional

To determine the effect of a whole soy food, dietary soy nuts, on blood pressure, lipid levels, inflammation and menopausal symptoms in postmenopausal women.

NCT ID: NCT01472393 Recruiting - Clinical trials for Postmenopausal Women

Creatine on Bone Mass in Postmenopausal Women

Start date: November 2011
Phase: N/A
Study type: Interventional

Animal, in vitro and small-scale studies have suggested that creatine supplementation may augment bone mass. This clinical trial aims to investigate the effects of a 2-year creatine supplementation protocol on bone mass in postmenopausal women.